These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 37124223)
41. A Computational Approach with Biological Evaluation: Combinatorial Treatment of Curcumin and Exemestane Synergistically Regulates DDX3 Expression in Cancer Cell Lines. Rampogu S; Kim SM; Son M; Baek A; Park C; Lee G; Kim Y; Kim GS; Kim JH; Lee KW Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32512851 [TBL] [Abstract][Full Text] [Related]
42. Salt-inducible kinases are required for the IL-33-dependent secretion of cytokines and chemokines in mast cells. Darling NJ; Arthur JSC; Cohen P J Biol Chem; 2021; 296():100428. PubMed ID: 33600797 [TBL] [Abstract][Full Text] [Related]
43. The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids. Verma SP; Goldin BR; Lin PS Environ Health Perspect; 1998 Dec; 106(12):807-12. PubMed ID: 9831541 [TBL] [Abstract][Full Text] [Related]
44. Dasatinib-SIK2 Binding Elucidated by Homology Modeling, Molecular Docking, and Dynamics Simulations. Shi M; Wang L; Li P; Liu J; Chen L; Xu D ACS Omega; 2021 Apr; 6(16):11025-11038. PubMed ID: 34056256 [TBL] [Abstract][Full Text] [Related]
45. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses. Arodola OA; Soliman ME Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167 [TBL] [Abstract][Full Text] [Related]
46. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations. Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525 [TBL] [Abstract][Full Text] [Related]
47. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726 [TBL] [Abstract][Full Text] [Related]
49. Discovery of novel pyrazolo[3,4-b]pyridine scaffold-based derivatives as potential PIM-1 kinase inhibitors in breast cancer MCF-7 cells. Nafie MS; Amer AM; Mohamed AK; Tantawy ES Bioorg Med Chem; 2020 Dec; 28(24):115828. PubMed ID: 33166925 [TBL] [Abstract][Full Text] [Related]
50. Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer Treatment. Ahmad I; Hoque M; Alam SSM; Zughaibi TA; Tabrez S Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047624 [TBL] [Abstract][Full Text] [Related]
51. Binding of curcumin with glyoxalase I: Molecular docking, molecular dynamics simulations, and kinetics analysis. Liu M; Yuan M; Luo M; Bu X; Luo HB; Hu X Biophys Chem; 2010 Mar; 147(1-2):28-34. PubMed ID: 20071071 [TBL] [Abstract][Full Text] [Related]
52. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors. Saeed MEM; Yücer R; Dawood M; Hegazy MF; Drif A; Ooko E; Kadioglu O; Seo EJ; Kamounah FS; Titinchi SJ; Bachmeier B; Efferth T Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409325 [TBL] [Abstract][Full Text] [Related]
53. Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations. Eldehna WM; El Hassab MA; Abo-Ashour MF; Al-Warhi T; Elaasser MM; Safwat NA; Suliman H; Ahmed MF; Al-Rashood ST; Abdel-Aziz HA; El-Haggar R Bioorg Chem; 2021 May; 110():104748. PubMed ID: 33684714 [TBL] [Abstract][Full Text] [Related]
54. Molecular Docking Simulation Studies of Curcumin and Its Derivatives as Cyclin-Dependent Kinase 2 Inhibitors. Sumirtanurdin R; Sungkar S; Hisprastin Y; Sidharta KD; Nurhikmah DD Turk J Pharm Sci; 2020 Aug; 17(4):417-423. PubMed ID: 32939138 [TBL] [Abstract][Full Text] [Related]
55. Involvement of SIK3 in glucose and lipid homeostasis in mice. Uebi T; Itoh Y; Hatano O; Kumagai A; Sanosaka M; Sasaki T; Sasagawa S; Doi J; Tatsumi K; Mitamura K; Morii E; Aozasa K; Kawamura T; Okumura M; Nakae J; Takikawa H; Fukusato T; Koura M; Nish M; Hamsten A; Silveira A; Bertorello AM; Kitagawa K; Nagaoka Y; Kawahara H; Tomonaga T; Naka T; Ikegawa S; Tsumaki N; Matsuda J; Takemori H PLoS One; 2012; 7(5):e37803. PubMed ID: 22662228 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages. Darling NJ; Toth R; Arthur JS; Clark K Biochem J; 2017 Feb; 474(4):521-537. PubMed ID: 27920213 [TBL] [Abstract][Full Text] [Related]
57. ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models. Nirgude S; Mahadeva R; Koroth J; Kumar S; Kumar KSS; Gopalakrishnan V; S Karki SS; Choudhary B Molecules; 2020 Sep; 25(19):. PubMed ID: 33008036 [TBL] [Abstract][Full Text] [Related]
58. A systems biology approach for elucidating the interaction of curcumin with Fanconi anemia FANC G protein and the key disease targets of leukemia. Mahato D; Samanta D; Mukhopadhyay SS; Krishnaraj RN J Recept Signal Transduct Res; 2017 Jun; 37(3):276-282. PubMed ID: 27608133 [TBL] [Abstract][Full Text] [Related]
59. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo. Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780 [TBL] [Abstract][Full Text] [Related]
60. Diketo modification of curcumin affects its interaction with human serum albumin. Shaikh SAM; Singh BG; Barik A; Ramani MV; Balaji NV; Subbaraju GV; Naik DB; Indira Priyadarsini K Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jun; 199():394-402. PubMed ID: 29635184 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]